133 related articles for article (PubMed ID: 28081947)
1. The effects of DPP-4 inhibitor on hypoxia-induced apoptosis in human umbilical vein endothelial cells.
Nagamine A; Hasegawa H; Hashimoto N; Yamada-Inagawa T; Hirose M; Kobara Y; Tadokoro H; Kobayashi Y; Takano H
J Pharmacol Sci; 2017 Jan; 133(1):42-48. PubMed ID: 28081947
[TBL] [Abstract][Full Text] [Related]
2. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
3. DPP-4 inhibition protects human umbilical vein endothelial cells from hypoxia-induced vascular barrier impairment.
Hashimoto N; Ikuma K; Konno Y; Hirose M; Tadokoro H; Hasegawa H; Kobayashi Y; Takano H
J Pharmacol Sci; 2017 Sep; 135(1):29-36. PubMed ID: 28923269
[TBL] [Abstract][Full Text] [Related]
4. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
[TBL] [Abstract][Full Text] [Related]
5. The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Chiazza F; Tammen H; Pintana H; Lietzau G; Collino M; Nyström T; Klein T; Darsalia V; Patrone C
Cardiovasc Diabetol; 2018 May; 17(1):60. PubMed ID: 29776406
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase‑4 inhibitor sitagliptin prevents high glucose‑induced apoptosis via activation of AMP‑activated protein kinase in endothelial cells.
Wu C; Hu S; Wang N; Tian J
Mol Med Rep; 2017 Jun; 15(6):4346-4351. PubMed ID: 28440488
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.
Marchetti C; Di Carlo A; Facchiano F; Senatore C; De Cristofaro R; Luzi A; Federici M; Romani M; Napolitano M; Capogrossi MC; Germani A
Diabetologia; 2012 Jan; 55(1):236-44. PubMed ID: 21656024
[TBL] [Abstract][Full Text] [Related]
9. DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells.
Ma Y; Wang J; Wang C; Zhang Q; Xu Y; Liu H; Xiang X; Ma J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3823-3831. PubMed ID: 31556325
[TBL] [Abstract][Full Text] [Related]
10. Anagliptin prevents apoptosis of human umbilical vein endothelial cells by modulating NOX-4 signaling pathways.
Li Q; Li J; Liu Y; Zhang M; Chen C
Biomed Pharmacother; 2018 Jul; 103():1623-1631. PubMed ID: 29864951
[TBL] [Abstract][Full Text] [Related]
11. The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory.
Pujadas G; De Nigris V; Prattichizzo F; La Sala L; Testa R; Ceriello A
Endocrine; 2017 Jun; 56(3):509-520. PubMed ID: 27530507
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
Ishibashi Y; Matsui T; Maeda S; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2013 Aug; 12():125. PubMed ID: 23984879
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
Wang J; Yu M; Xu J; Cheng Y; Li X; Wei G; Wang H; Kong H; Xie W
J Biomed Sci; 2019 Jan; 26(1):6. PubMed ID: 30634956
[TBL] [Abstract][Full Text] [Related]
14. DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway.
Mi DH; Fang HJ; Zheng GH; Liang XH; Ding YR; Liu X; Liu LP
CNS Neurosci Ther; 2019 Mar; 25(3):323-332. PubMed ID: 30136405
[TBL] [Abstract][Full Text] [Related]
15. Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced β cell apoptosis via inhibiting dipeptidyl peptidase-4.
Huang CN; Wang CJ; Lee YJ; Peng CH
PLoS One; 2017; 12(7):e0180285. PubMed ID: 28715446
[TBL] [Abstract][Full Text] [Related]
16. Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes.
Fiordaliso F; Maggioni S; Balconi G; Schiarea S; Corbelli A; De Luigi A; Figliuzzi M; Antoniou X; Chiabrando C; Masson S; Cervo L; Latini R
Life Sci; 2016 Jun; 154():87-95. PubMed ID: 27040669
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine protects CoCl2-induced apoptosis in human umbilical vein endothelial cells by regulating the PHD2/HIF/1α-VEGF pathway.
Yang C; Xu Y; Zhou H; Yang L; Yu S; Gao Y; Huang Y; Lu L; Liang X
Mol Med Rep; 2016 Feb; 13(2):1287-96. PubMed ID: 26676934
[TBL] [Abstract][Full Text] [Related]
19. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
[TBL] [Abstract][Full Text] [Related]
20. Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines.
Busek P; Stremeňová J; Krepela E; Sedo A
Physiol Res; 2008; 57(3):443-449. PubMed ID: 17949241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
